In drug development, accurately setting and reaching the target is a very important factor in increasing the selectivity of the drug to the cause of the disease, thereby improving the efficacy of the drug and reducing side effects.
This principle has been followed for a long time and is still an essential strategy in drug development. Recently, as various causes of diseases have been revealed and it has been revealed that there are many correlations between diseases, there is a continuing demand for new drugs that can reach multiple targets.
We have accumulated technology and know-how in designing small molecule that can perform multiple functions by reaching multiple targets in a single molecule.
This technology is a combination of the rational design and the artificial intelligence-based design. This approach can significantly shorten the time required for the selection of candidate substances.
We have built a number of small molecule pipelines for this technology, and we can produce from the small amount of synthesis stage of the discovery stage to the commercial production under GMP management in small molecule synthesis.
In addition to our pipelines, design and synthesis can also be performed through collaborative research for this technology.
